基于外体的免疫疗法作为黑色素瘤的创新治疗方法
Shabnam Babaei1,2, Manouchehr Fadaee2,3, Hajar Abbasi-Kenarsari4
1Immunology Research Center , Tabriz University of Medical Sciences, Tabriz, Iran.
Cell communication and signaling : CCS
|November 1, 2024
概括
外体细胞通过输送治疗剂显示出治疗晚期黑色素瘤的前途. 这种方法利用它们的生物相容性和低免疫性,增强癌症治疗策略.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 纳米技术 纳米技术
背景情况:
- 黑色素瘤是一种致命的癌症,在历史上,晚期的癌症有着不良的预后.
- 了解瘤微环境 (TME) 的进步刺激了新型免疫治疗的发展.
- 免疫疗法显著改善了转移性黑色素瘤患者的生存率.
研究的目的:
- 审查最近在利用外体组治疗黑色素瘤的进展.
- 突出外体的潜力作为在瘤学中的药物输送载体.
主要方法:
- 目前针对黑色素瘤的基于外体的疗法研究的文献综述.
- 对药物输送和免疫调节相关的外体属性的分析.
主要成果:
- 外体是小的细胞外囊泡 (EVs),具有自然的生物相容性和低免疫性.
- 外体可以被设计为提供各种治疗剂,包括化疗药物和核酸.
- 它们的特性使它们成为向黑色素瘤治疗的合适候选人.
结论:
- 外体构成一个有前途的平台,用于开发先进的黑色素瘤治疗.
- 对基于外体的治疗方法的进一步研究可能会改善晚期黑色素瘤患者的治疗结果.
相关概念视频
Tumor Immunotherapy
484
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
484
Cancer Vaccines
341
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
341
Overview of Exosomes
2.7K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K


